<DOC>
	<DOC>NCT00451932</DOC>
	<brief_summary>A proof of concept study to evaluate the safety and effectiveness of FK778 in liver transplant patients.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients</brief_title>
	<detailed_description />
	<criteria>Male or female patients at least 18 years of age and not older than 65 years. Female patients of child bearing potential must have a negative serum pregnancy test prior to enrollment and must agree to practice effective birth control during the study. Male patients must agree to practice effective birth control methods during the study. Patient is a recipient of a primary whole cadaveric liver transplant Patient has previously received or is receiving an organ transplant other than a liver. Patient has received an ABO incompatible donor liver. Patient or donor is known to be HIV positive. Patient has a current malignancy or a history of malignancy (within the past 5 years), except nonmetastatic basal or squamous cell carcinoma of the skin that has been treated successfully. Patient is being transplanted for hepatic malignancy with a single nodule greater than 5.0 cm in diameter or 2 or more nodules with at least one &gt; 3.0 cm. Patient has a serum creatinine &gt;175 Âµmol/L at baseline. Patient has uncontrolled concomitant infections and/or severe diarrhoea, vomiting, active upper gastrointestinal tract malabsorption or an active peptic ulcer or any other unstable medical condition that could interfere with the study objectives. Patient who is receiving or may require warfarin or fluvastatin during the study. Patient is participating in another clinical trial and/or is taking or has been taking an investigational drug in the 28 days prior to transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Malononitrilamide</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>treatment efficacy</keyword>
	<keyword>treatment effectiveness</keyword>
</DOC>